Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. Year to date metric has recorded a loss of -9.87%.However, over the last six months, we can see a stronger performance of -9.72%. Over the last 30 days, the price of TVTX has leaped by -5.99%. And in the last five days, it has fallen by -25.77%.
Travere Therapeutics Inc experienced a somewhat steady performance in the stock market. The company’s stock reached a 1-year high of $25.29 on 02/11/25, while the lowest price for the same period was registered at $6.14 on 05/24/24.
52-week price history of TVTX Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Travere Therapeutics Inc’s current trading price is -37.92% away from its 52-week high, while its distance from the 52-week low is 155.70%. The stock’s price range during this period has varied between$6.14 and $25.29. The Travere Therapeutics Inc’s shares, which operate in the Healthcare, saw a trading volume of around 1.62 million for the day, a figure considerably lower than their average daily volume of 1.81 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Travere Therapeutics Inc (TVTX) has experienced a quarterly decline of -28.57% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.39B and boasts a workforce of 385 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 19.24, with a change in price of -2.08. Similarly, Travere Therapeutics Inc recorded 1,715,855 in trading volume during the last 100 days, posting a change of -11.70%.
TVTX’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for TVTX stands at 12.20. Similarly, the long-term debt-to-equity ratio is also 9.94.
TVTX Stock Stochastic Average
Travere Therapeutics Inc’s raw stochastic average for the past 50 days is presently 30.46%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 0.47%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 10.00% and 17.91%, respectively.
